Documente Academic
Documente Profesional
Documente Cultură
of the structures,
reactivities,
and reaction
mechanisms of
metalloenzymes
Electronic structure theory, which in recent
years has been actively and effectively applied
to the modeling of chemical reactions
involving transition-metal complexes, is
now also being applied to the modeling
of biological processes involving
metalloenzymes. In the first part of this paper,
we review our recent electronic structure
studies using relatively simple models of two
metalloenzymesmethane monooxygenase
and ribonucleotide reductase. In the second
part of the paper, we review a new hybrid
theoretical method we have developed for
modeling the reactivities of large molecular
systems. We describe the limitations of these
models and indicate how they may be further
improved to reliably model the reactivities of
complicated metalloenzymes.
1. Introduction
Modeling the reactivities of biological systems is currently
one of the long-range goals of computational chemistry.
In the field of bioinorganic chemistry, which includes
metalloenzyme chemistry, because of improved
by K. Morokuma
D. G. Musaev
T. Vreven
H. Basch
M. Torrent
D. V. Khoroshun
Copyright 2001 by International Business Machines Corporation. Copying in printed form for private use is permitted without payment of royalty provided that (1) each
reproduction is done without alteration and (2) the Journal reference and IBM copyright notice are included on the first page. The title and abstract, but no other portions, of this
paper may be copied or distributed royalty free without further permission by computer-based and other information-service systems. Permission to republish any other portion of
this paper must be obtained from the Editor.
0018-8646/01/$5.00 2001 IBM
K. MOROKUMA ET AL.
367
368
K. MOROKUMA ET AL.
(1)
II
(2)
Glu243
Glu243
O
O
OH2
CH3
His147
O
Fe2
O
H
H 2O
Fe1
His246
His147
Glu209
Glu114
O
Fe1
OH2
Glu209
Glu114
O
Glu238
O
Fe2
O
H
O
Glu144
Glu144
(4oC)
(-160oC)
OH2
Asp84
His246
His118
His241
O
O
Glu115
Glu238
Glu209
Glu243
O
OH2
His147
Fe2
Fe1
O
Fe2
R2met
O
O
H 2O
O
Fe1
MMOHox
Glu114
Glu204
Asp84
Fe2
Fe1
His118
OH2
His246
O
Glu204
His241
O
Glu144
Glu115
MMOHred
R2red
Scheme 1
Structural representation of the binuclear Fe center of MMOHox , R2met , MMOHred , and R2red (see Reference [1]).
K. MOROKUMA ET AL.
369
H(2)
O
2e -
O
H(2)
O
FeIII
FeIII
O2
FeII
FeII
O
O
Compound O
MMOHred
O
O
O
FeIII
MMOHox
CH3OH
FeIII
O
O
Intermediate P
CH4
FeIV
FeIV
O
O
O
Intermediate Q
Scheme 2
Experimentally proposed catalytic cycle of MMO.
370
K. MOROKUMA ET AL.
Fe1(II)
Fe2 (II)
H2O
NH2
H 2O
NH2
O
H
(a)
H
H
O
O
O
Fe1(II)
Fe2 (II)
H
CH3
CH3
H
N
N
(b)
Scheme 3
Models used in the present studies. (a) Small model; (b) medium
model.
K. MOROKUMA ET AL.
371
1.265
1.324
2.135
1.329
1.282
1.937
2.650
1.261
1.984
1.655
b
2.098
3.415
2.150
Fe 1
2.165
2.146
Fe 1
1.300
2.010
2.107
C
1.305
Fe1 Fe2 = 4.022
1.295
1.270
O
2.084 1.329
2.204
Fe 1
2.304
2.145
2.158
1.624
b
2.093
2.112
1.273
1.950
2.543
1.299
C
2.063
1.295
N
1.276
1.301
1.299
1.598
1.978
Fe 2
2.004
2.075
2.146
2.114
1.271
2.032
O
C
1.302
O
C
Fe 1
2.391
2.078
2.160
2.140
Fe2
1.268
1.325
d 1.257
2.078
1.998
1.300
Fe 2
2.002
1.277
1.610
N
C
C
O
2.064
1.291
b 2.018
2.112
Fe 2
2.075
2.082
Figure 1
Optimized geometries of the equilibrium structures (distances in ).
372
K. MOROKUMA ET AL.
2.011
1.263
1.611
3.218
2.152
Fe1
2.147
2.168
1.296
O
1.300
1.290
1.326
2.059
2.077
2.321
d
2.147
Fe1 Fe2
Fe1 Fe2
= 3.805
1.267
2.111
b
2.095
2.127
C
2.119
2.174
1.276
1.305
1.980
Fe 2
2.095
1.296
O
2.004
C
Fe 2
2.003
N
N
2.067
O
N
C
C
C
O
2.145
2.601
1.270
1.302
1.285
2.003
2.122
Fe1 Fe2
2.080
1.276
b
2.126 1.595
Fe 1
2.034
= 3.800
TS34 Nimag =1, 84 i cm-1
2.550
Fe 1
1.305
O
O
2.750
1.335 1.596
1.271
1.298
1.308
1.281
Fe 2
2.043
1.277
2.140
1.968
2.084
2.131
N
C
C
C
O
O
O
1.597
2.147 b 2.497
Fe1
N
N
1.292
O
2.068
2.179
1.295
C
1.978
Fe 2
2.498
1.296
O
C
1.302
= 4.006
Figure 2
Optimized geometries of the transition states (distances in ).
K. MOROKUMA ET AL.
373
1,2-carboxylate shift
MMOH-like
R2-like
O
C
C
O
O
O
Fe
Fe
Fe
Fe
Fe
Fe
O
C
1
0.0 kcal/mol
O
C
2
-7.9 kcal/mol
TS12
0.7 kcal/mol
C
O
O
O
Fe
Fe
TS13
1.0 kcal/mol
O
Fe
Fe
TS24
-6.5 kcal/mol
O
C
(m)
(b)
rearrangement
(m)
(b)
rearrangement
TS34
-0.2 kcal/mol
O
O
C
O
Fe
Fe
Fe
Fe
Fe
Fe
MMOH-like
3
-1.8 kcal/mol
O
C
4
-6.7 kcal/mol
O
C
R2-like
1,2-carboxylate shift
Figure 3
Schematic representation of the reaction mechanism and the energetics of 1,2-carboxylate shift (horizontal) and monodentate
rearrangement (vertical) in MMOH-like and R2-like systems. For clarity, ligands not directly involved have been omitted.
374
K. MOROKUMA ET AL.
bidentate
Glu243
1
Glu209
4
3
Glu114
Fe
2
Fe
His147
His246
Glu144
Scheme 4
Experimentally proposed possible substrate coordination sites.
K. MOROKUMA ET AL.
375
H2O
H2O
C
O
N
Fe
H2O
Fe
+ O2
O2
O
O
Fe
Fe
Fe
Fe
II_R2
+ O2
I_R2-like
I_MMOH-like
O
H2O
C
O
H2O
N
Fe
Fe
Fe
Fe
Fe
Fe
H2O
O
O
O
O
O2
III_R2
III_MMOH
II_MMOH
Homolytic OO activation
H2O
C2
O3
O4
N
O6
O3
C1
Fe 1
O3
O2
C1
O5
O1
O1
O2
O2
N
Fe 1
Fe 2
O1
O6
Fe 1
Fe2
C1
Fe2
O7
O
O4
O5
O4
VI_R2, Q
O5
C2
C2
IV
O4
C2
H 2O
O3
N
O6
Fe 2
Fe 1
O5
O
O2
O1
C1
VI_MMOH, Q
Scheme 5
Proposed mechanism for the dioxygen coordination and homolytic O O bond cleavage on MMOHred and R2red. Here, N is the nitrogen-bearing
ligand, His, while O represents oxygen-bearing ligands such as Glu and Asp.
376
K. MOROKUMA ET AL.
III_R2
III_MMOH
+ H+
+ H+
H2O
H2O
N
Fe
O
O
Fe
Fe
Fe
O
OH
OH
VII_R2
VII_MMOH
+ H+
H2O
+H+
H2O
H2O
H2O
N
Fe
O
O
Fe
Fe
Fe
O
C
VIII_R2
O
O
O
C
VIII_MMOH
Scheme 6
Proposed mechanism for the heterolytic OO bond cleavage on MMOHred and R2red. Here, N is the nitrogen-bearing ligand, His, and O represents
oxygen-bearing ligands such as Glu and Asp.
K. MOROKUMA ET AL.
377
378
K. MOROKUMA ET AL.
(3)
Fe-Fe = 2.692
(2.945)
O
Fe1
2.019
O (2.107)
1.729
O
(2.013)
Fe
1.973
1.250
1.271
O
O
IX
O2
1.730
(2.017)
2.017
(2.106)
1.104
(1.104)
1.949
1.779 Fe 2
Fe 1
2.014
Fe
Fe
2
2.367 O
1.488 2.471
C
O
O
O
C
O1
Fe2
Fe1
(2.001)
(1.296)
O
Fe 2
(2.057) O2
(2.190) O1
Fe1
(4.512)
(1.952)
Fe1
(2.400)
(2.097)
Fe
(1.743)
(2.150) O
Fe
Fe
C
O
Fe
XIV, 9A
TS2
XIII, 9A
Fe
O
(2.084)
O2
(1.979)
O (1.798) Fe2
Fe1
O
O
(72.3)
Fe2
O2
Fe
(1.986)
TS1
XI, (11A)
C
O
(2.974)
(5.061)
11
(2.384) XII, ( A)
Fe
(2.185)
(1.468)
9A (11A)
4.805
Fe
(1.241)
2.595
(2.674)
2.089 2
O 86.1
2.250
XII, 9A
(1.737)
Fe
(1.732)
(2.188)
Fe
(H3C)HO = (177.7)
OOH = (137.0)
O
Fe
O1
Fe
Fe
O
Fe-Fe = 2.692
(2.945)
1.785
O1 (1.741) Fe 2
O2
1.913
Fe
O
O
O
O
1.741
O1
Fe2
Fe
TS1
XI, 9A
9A (11A)
1.919
(2.215)
1.923
Fe1
1.984
4.587
2.185
Fe 2
Fe
N
O2
O11.732
2.186
Fe
1.744 Fe 2
Fe
Fe
O
2.146
O
O
Fe-Fe = 2.958
2.098
1.785
1.921 (1.737)
(2.185) 1
Fe2
O
Fe
Fe-Fe = 2.882
Fe-Fe = 2.903
OOH = 172.5
Fe-Fe = 2.866
C
C
O
TS2
XIII, (11A)
XIV, (11A)
Figure 4
Calculated structures (distances in , angles in degrees) of the intermediate and transition states of the reaction: (NH2)(H2O)Fe(-O)2( 2(NH2)(H2O)Fe(-O)(-HOCH3)(2-HCOO)2Fe(NH2)(H2O). Numbers for the 9A state are without parentheses and
HCOO)2Fe(NH2)(H2O) + CH4
those for the 11A state are in parentheses.
2
the O HCH3 fragment. For the CH3 group, the spin
9
11
densities for A and A are 0.46 and 0.52, respectively.
Overcoming the transition state XI leads to the product
XII, in which the Fe centers are bridged by one O and
one OH ligand. XII is an oxo-hydroxyl complex, formally
written as L4 Fe(-O)(-OH)FeL4 , with the methyl radical
only weakly interacting via a CHO interaction.
As seen in Table 1, in the intermediate XII, the CH3
group is now a bound radical with spin densities of 0.98
9
11
and 1.00 for the A and A states, respectively. The spin
1
2
densities on Fe and Fe in XII can qualitatively be
IV
considered to correspond to Fe with four spins
III
9
11
and Fe with five spins, for the A and A states,
respectively.
The spin densities of the complex IX, transition
states XI, and products XII presented in Table 1 can be
interpreted in the following way. In structure XI, the total
of eight and ten unpaired electrons (spins) of the 9 A
11
and A states, respectively, are equally localized on two
Ln FeO groups. According to the discussions presented
9
above, one may consider IX (and X) in the A state as an
IV
IV
11
[Fe Fe ] complex, and IX (and X) in the A state as
IV
III
an [Fe Fe ] mixed-valence complex. In both transition
states XI, a radical center begins to develop on the CH3
group, with spin densities of 0.46 and 0.52 for the 9 A
and 11 A states, respectively. In the intermediate XII, the
CH3 group becomes a bound radical with spin densities of
K. MOROKUMA ET AL.
379
Table 1 Mulliken atomic spin densities for the various intermediates and transition states of the MMO methane reaction,
calculated at the B3LYP/SBK level.
Structures
Fe 2
O1
3.17
3.16
3.40
3.32
3.28
2.80
3.37
3.36
4.09
4.15
4.14
4.15
0.33
0.31
0.56
0.59
0.50
0.35
3.35
3.37
3.35
3.34
3.61
4.10
4.10
4.10
4.12
4.14
4.14
4.13
0.57
0.58
0.59
0.59
0.55
0.57
H*
CH3 **
0.45
0.45
0.22
0.19
0.21
0.04
0.03
0.00
0.00
0.00
0.46
0.98
0.81
0.00
1.21
1.21
0.74
0.22
0.10
0.05
0.05
0.02
0.00
0.00
0.52
1.00
0.85
0.00
A states
IX
X
XI
XII
XIII
XIV
11
A states
IX
X
XI
XII
XIII
XIV
380
O2
K. MOROKUMA ET AL.
Perspective
The above calculations using small and medium-sized
models have already provided new insights into the
mechanisms of reactions and transformations in the MMO
30
23.2
11A
20
18.2
19.5
C
9A
Fe
Fe
17.6
11.8
8.8
10
E (kcal/mol)
11.4
Hydroxyl
complex, XII
Reactants CH activation
IX
TS1, XI
O
O
Fe
Fe
O
O
O
Fe
Fe
N
C
O
O
C
C
O
CH3 addition
TS2, XIII
C
O
C
O
HOCH3
complex, XIV
Fe
Fe
O
O
-10
Fe
Fe
C
N
9A
-20
-30
-40
11A
-31.4
-39.8
Figure 5
Potential energy profile (in kcal/mol) at the B3LYP/SBK(CO*)//B3LYP/SBK
level for both the 9A state and the 11A state of the methane activation
reaction: (NH2)(H2O)Fe(-O)2(2-HCOO)2Fe(NH2 )(H2O) CH4 _
(NH2 )(H2O)Fe(-O)(-HOCH3)(2-HCOO)2Fe(NH2 )(H2O).
K. MOROKUMA ET AL.
381
Table 2
Theoretical methods for calculating molecular structure and the energy of molecular systems.
Approximation
Reliability
Size
dependency
No. of non-H
atoms
Quantitative
(2 kcal/mol)
Semiquantitative
Semiquantitative
Qualitative
N 6
5 6
N 4
N 3
N 3
10 50
50 100
100 200
Semiempirical MO methods
AM1, PM3, MNDO
Semiqualitative
N 23
1000
Semiqualitative
N 12
10 3 4
Ab initio MO methods
CCSD(T)/QTZ
MP2/DZP
DFT(B3LYP)/DZP
HF/DZ
382
K. MOROKUMA ET AL.
High
Low
Model
Real
(a)
Model
Medium
Intermediate
(b)
Real
Figure 6
Schematic representation of (a) two-layer and (b) three-layer ONIOM
extrapolation schemes.
(4)
K. MOROKUMA ET AL.
383
high
medium
medium
low
384
E ONIOM
(5)
K. MOROKUMA ET AL.
high
E model
low
E real
low
E model
(6)
(7)
high
E model
low
E real
low
E model
J.
(8)
Bond dissociation energies (kcal/mol) using a minimal model. See references for specific procedures and origin of
experimental data.
Table 3
Reaction a
PhF
PhCH3
PhSiH2 H
PhCH2 SCH3
F5 SOOSF5
PhCH2 H
MePhCHH
Me2 PhCH
Ph2 CHH
MePh2 CH
Ph3 CH
PhCH2 CH3
MePhCHCH3
Me2 PhCCH3
Ph2 CHCH3
MePh2 CCH3
Ph3 CCH3
Ref. b
Experimental
G2MS(R):RMP2 c
G2MS(U):RMP2 c
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
125.7 2
101.8 2
88.2
61.4 2
37.2 2
88.0 1
85.4 1.5
84.4 1.5
84 2
81 2
n.a.
75.8 1
74.6 1.5
73.7 1.5
72 2
69 2
n.a.
124.6
100.3
86.3
61.6
37.3
90.1
87.8
87.2
82.6
82.6
75.9
79.0
78.1
77.2
72.7
72.9
64.1
125.2
101.9
86.3
62.4
37.7
90.4
88.2
87.6
82.9
82.9
79.7
78.9
77.9
73.5
73.6
G2MS(R):RMP2:RHF d
C60 :S0 3 T1 ( bond)
III
36.1
35.1
G2MS(R):RMP2:B3LYP e
Ph3 CCPh3
IV
n.a.
16.4
K. MOROKUMA ET AL.
385
Butadiene butadiene
Acrolein isoprene
Maleic anhydride isoprene
Maleic anhydride
2-tert-butyl-1,3-butadiene
G2MS:MP2
Experimental
23.5
17.6
9.2
4.6
Table 5
386
Ethylene 1
Acetylene 1
K. MOROKUMA ET AL.
Product ratios
1,2,cis
1,2,trans
1,3,cis
1,3,trans
75.5 (61)
22.9 (22)
0.9 (9)
0.7 (8)
syn
anti
99.9 (93)
7.2 (8)
0.1 (7)
92.8 (92)
1.429 1.394
(1.511) (1.315)
[1.412] [1.430]
1.010
(1.038)
[1.004]
2.253
(2.217)
[2.269]
1.600
(1.562)
[1.650]
0.981
(1.000)
[0.995]
1.708
(1.700) 0.992
[1.728] (1.010)
[1.006]
0.998
(1.018)
1.664 [1.012]
(1.650)
[1.690]
(a)
3.4 kcal/mol
(4.3)
[0.1]
0.998
1.531
(1.014)
(1.543)
[1.013]
2.106 2.107
[1.567]
(2.121) (2.121)
1.033
1.033 (1.052)
[2.122] [2.122]
0.998 1.529
(1.051) [1.026]
(1.014) (1.543)
[1.026]
[1.013] [1.565]
2.109
(2.122)
[2.126]
1.033
(1.051)
[1.026]
0.998
(1.014)
[1.013]
1.531
(1.544)
[1.567]
(b)
0.0 kcal/mol
(0.0)
[0.8]
0.990
(1.007)
[1.004]
1.640
1.004
(1.638) (1.024)
[1.674] [1.017]
1.484
(1.476)
2.164
[1.548]
1.872 1.046
(2.162)
1.043
[2.192] (1.943) (1.054)
(1.070)
[1.789] [1.070]
[1.029]
1.010
(1.030)
2.311
[1.003]
(2.280)
1.650
[2.364]
0.986
(1.651)
(1.003)
[1.725]
[0.998]
(c)
2.0 kcal/mol
(2.1)
[0.0]
Figure 7
Optimized structures (in ) and relative energies (in kcal/mol) of three
forms of (HCl)(H2O)4 at levels B3LYP/D95++(d,p), BLYP/D95+(d)
(in parentheses), and ONIOM(B3LYP/D95++(d,p): BLYP/D95+(d))
[in brackets; the model system is (HCl)(H2O)].
387
K. MOROKUMA ET AL.
Table 6
High
S high
Low
S low
Model
level
level
E real E model ,
(9)
ONIOM
high
low
low
(10)
Toluene
G2MS(R)
UHF
RHF
UMP2
RMP2
7.75(0.00)
7.29(0.46)
6.73(1.02)
7.72(0.03)
8.10(0.35)
16.21(0.00)
26.12(9.91)
10.28(5.93)
6.93(23.14)
15.04(1.17)
(CH3)3CH 3 (CH3)3C H.
level
Iso-butane
Real
Scheme 7
Level
(CH3)3CH 3 (CH3)3C H;
K. MOROKUMA ET AL.
ES,ONIOM
ES,low
E real
ES,low
ES,high
E model E model .
(11)
H
N
Fe
Pr
N
H
H
(a)
H
i Pr
Me
N
i Pr
Fe
Pr
i Pr
N
Me
i Pr
(b)
Scheme 8
Two models used in the study: (a) Model 1: Low steric bulk (LSB):
B3LYP/BS III // B3LYP/BS I; (b) Model 2: High steric bulk (HSB)
IMOMM (B3LYP/BS III : MM3) // IMOMM (B3LYP/BS II : MM3).
K. MOROKUMA ET AL.
389
+30
BHT chain
termination TS
+20
+15.0
[+19.1]
+10
+10.2
[+18.6]
Agostic -complexes
0
E0MO
-7.7
[+3.8]
-11.9
[+0.4]
-20
-1.2
[+10.2]
-4.4
[+9.3]
-7.7
[+4.6]
-13.5
[-4.8]
-10
Chain propagation
TS
-5.6
[+5.2]
-6.2
[+1.4]
-15.1
[-1.2]
-6.2
[+8.8]
-21.4
[-13.2]
-19.4
[-5.9]
-30
-21.0
[-13.1]
-25.7
[-20.9]
-26.2
[-21.7]
-40
(m-V)
CH3
H2
C CH
N3 Fe
C C
H2 H2
(m-II-1-) (m-II-1-)
(m-II-2-)
(m-II-2-)
CH3
H2 CH3 H C CH3
H
2
H CH
C CH
CH3
CH H N3 Fe CH
C
N3 Fe CH2
N3 Fe H
H2C CH2 H2
N3 Fe
H2C CH2
H2C CH2
H2C CH
(m-III-)
(m-III-)
H
N3 Fe
H 2C
CH3
CH
C
H2
C
H2
N3
H 2C
CH3
H CH
Fe CH2
C
H2
Figure 8
Competition between chain propagation and BHT chain-termination mechanism in LSB system. B3LYP/BSIII//B3LYP/BSI potential energy
surfaces (in kcal/mol; Gibbs free-energy energies in square brackets) for alkyl ethylene -complexes (m-II), propagation transition states (m-III),
and BHT transition states (m-V). Relative to (m-I-1- S) C2H4. Singlet species: thick line; triplet species: thin line; quintet species: dashed line.
390
K. MOROKUMA ET AL.
+30
Agostic -complexes
BHT chain
termination TS
Chain propagation
TS
+20
+10
+11.7
+6.3
-1.4
-2.8
0
EIMOMM
+5.2
+3.2
+2.3
+8.7
-4.2
-8.9
-10
-17.3
-20.2
-20
-17.9
-21.9
-30
-40
(r-V)
(r-II-1-)
CH3
H2 CH3
C CH
H2
C CH
N3 Fe
C C
H2 H 2
N3 Fe H
H2C
CH2
(r-II-1-) (r-II-2-)
H2C
CH3
H
CH H N3 Fe CH
H2C CH2
N3 Fe
H2 C
CH2
(r-II-2-)
CH3
H CH
CH3
C
N3 Fe CH2
H2
H2C CH2
(r-III-)
(r-III-)
CH3
H CH
CH
3
N3 Fe CH
C N3 Fe CH2
H 2C C H
2
H2
H 2C C
H2
H
Figure 9
Competition between chain propagation and BHT chain-termination mechanism in HSB system. IMOMM(B3LYP/BSIII:MM3)//IMOMM(B3LYP/BSII:MM3)
potential energy surfaces (in kcal/mol) for alkyl ethylene -complexes (r-II), propagation transition states (r-III), and BHT transition states (r-V).
Relative to (r-I-1- S) C2H4. Singlet species: thick line; triplet species: thin line; quintet species: dashed line.
K. MOROKUMA ET AL.
391
E (hartrees)
440.995
441.000
Model
441.005
H
H
441.010
441.015
441.020
ONIOM
Target
441.025
441.030
0.00
N
H
1.00
7.00
8.00
Figure 10
Target CASSCFS1(10e,10o)/6-31G(d) and ONIOM(CASSCFS1(8e,8o)/631G(d):UHFT1/3-21G) curves for an S1 photoisomerization path of an
11 non-H model for retinal protonated Schiff base.
392
K. MOROKUMA ET AL.
Acknowledgment
The research presented here is partially supported by National
Science Foundation Grant No. CHE-9627775. We wish
to acknowledge all collaborators, visiting fellows,
postdoctoral fellows, and graduate students who
participated in the MMO/RNR project and the ONIOM
project.
References
1. (a) B. J. Waller and J. D. Lipscomb, Chem. Rev. 96, 2625
(1996) and references therein; (b) E. Solomon, T. C.
Brunold, M. I. Davis, J. N. Kemsley, S.-K. Lee,
N. Lehnert, F. Neese, A. J. Skulan, Y.-S. Yang, and J.
Zhou, Chem. Rev. 100, 235 (2000) and references therein.
2. R. E. Stenkamp, Chem. Rev. 94, 715 (1994).
3. (a) A. L. Feig and S. J. Lippard, Chem. Rev. 94, 759
(1994); (b) K. E. Liu and S. J. Lippard, Adv. Inorg.
Chem. 42, 263 (1995); (c) B.-M. Sjoberg, Structure of
Ribonucleotide Reductase from Escherichia Coli, Vol. 9,
F. Eckstein and D. M. J. Lilley, Eds., Springer-Verlag,
Berlin, 1995, pp. 192221.
4. (a) See Reference 1 and references cited therein;
(b) L. Shu, J. C. Nesheim, K. Kauffmann, E. Munck, J. D.
Lipscomb, and L. Que, Jr., Science 275, 515 (1997).
5. B. G. Fox, J. Shanklin, C. Somerville, and E. Munck,
Proc. Natl. Acad. Sci. USA 90, 2486 (1993).
6. I. Nordlund, J. Powlowski, and V. Shingler, J. Bacteriol.
172, 6826 (1990).
7. J. Shanklin, E. Whittle, and B. G. Fox, Biochemistry 33,
12787 (1994).
8. L. M. Newman and L. P. Wackett, Biochemistry 34, 14066
(1995).
9. J. D. Pikus, J. M. Studts, C. Achim, K. E. Kauffmann,
E. Munck, R. J. Steffan, K. McClay, and B. G. Fox,
Biochemistry 35, 9106 (1996).
10. (a) T. Klabunde, N. Strater, R. Frohlich, H. Witzel, and
B. Krebs, J. Biol. Chem. 259, 737 (1996); (b) T. Klabunde
and B. Krebs, Struct. Bonding 89, 177 (1997).
11. (a) F. Bonomi, D. M. Kurtz, Jr., and X. Cui, J. Bioinorg.
Chem. 1, 67 (1996); (b) E. D. Coulter, N. V. Shenvi, and
D. M. Kurtz, Jr., Biochem. Biophys. Res. Commun. 255,
317 (1999); (c) F. deMare, D. M. Kurtz, Jr., and P.
Nordlund, Nat. Struct. Biol. 3, 539 (1996).
12. (a) H. Takagi, D. S. Shi, Y. Ha, N. M. Allewell, and E. C.
Thiel, J. Biol. Chem. 273, 18685 (1998); (b) P. MoenneLoccoz, C. Krebs, K. Herlihy, D. E. Edmondson, E. C.
Thiel, B. H. Huynh, and T. M. Loehr, Biochemistry 38,
5290 (1999); (c) Y. Ha, D. S. Shi, G. W. Small, E. C.
Thiel, and N. M. Allewell, J. Bioinorg. Chem. 4, 243
(1999); (d) Z. Gdaniec, G. H. Sierzputowska, and E. C.
Thiel, Biochemistry 38, 5676 (1999); (e) J. Hwang,
C. Krebs, B. H. Huynh, D. E. Edmondson, E. C. Thiel,
and J. E. Penner-Hahn, Science 287, 122 (2000).
13. (a) V. J. DeRose, K. E. Liu, D. M. Kurtz, Jr., B. M.
Hoffman, and S. J. Lippard, J. Amer. Chem. Soc. 115,
6440 (1993); (b) B. G. Fox, M. P. Hendrich, K. K.
Surerus, K. K. Andersson, W. A. Froland, and J. D.
Lipscomb, J. Amer. Chem. Soc. 115, 3688 (1993); (c) H.
Thomann, M. Bernardo, J. M. McCormick, S. Pulver,
K. K. Andersson, J. D. Lipscomb, and E. I. Solomon,
J. Amer. Chem. Soc. 115, 8881 (1993).
14. (a) See Reference 1 and references cited therein;
(b) J. Stubbe, J. Biol. Chem. 265, 5329 (1990); (b) B.-M.
Sjoberg and A. Graslund, in Advances in Inorganic
Biochemistry, E. C. Thiel, G. L. Eichorn, and L. G.
Marzilli, Eds., Elsevier, New York, 1983, ch. 5, p. 87; (c)
P. Reichard and A. Ehrenberg, Science 221, 514 (1983).
15. (a) See Reference 1 and references cited therein;
(b) P. Reinchard, Science 260, 1773 (1993); (c) J. Stubbe
and W. A. van der Donk, Chem. Rev. 98, 705 (1998);
(d) E. Mulliez and M. Fontecave, Coord. Chem. Rev.
185186, 775 (1999); (e) P. Nordlund, B. M. Sjoberg, and
H. Eklund, Nature 45, 593 (1990).
16. W. C. Voegtli, N. Khidekel, J. Baldwin, B. A. Ley, J. M.
Bollinger, Jr., and A. C. Rosenzweig, J. Amer. Chem. Soc.
122, 3235 (2000) and references therein.
17. M. E. Andersson, M. Hogbom, A. Rinaldo-Matthis, K. K.
Andersson, B.-M. Sjoberg, and P. Nordlund, J. Amer.
Chem. Soc. 121, 2346 (1999).
K. MOROKUMA ET AL.
393
394
K. MOROKUMA ET AL.
395
K. MOROKUMA ET AL.